Advertisement

Topics

Rodman & Renshaw Conferences, LLC Company Profile

10:56 EDT 6th May 2016 | BioPortfolio


News Articles [223 Associated News Articles listed on BioPortfolio]

Valeant Pharmaceuticals-Aktie: Unternehmen wurde unfair behandelt und ist geschützt! - Aktienanalyse

New York - Valeant Pharmaceuticals-Aktienanalyse von Analyst Raghuram Selvaraju von Rodman & Renshaw: Raghuram Selvaraju, Aktienanalyst vom Investmenthaus Rodman & Renshaw, spricht im Rahmen einer ...

Valeant Pharmaceuticals-Aktie: Restatements sind niemals gut, aber... - Aktienanalyse

New York - Valeant Pharmaceuticals-Aktienanalyse von Analyst Raghuram Selvaraju von Rodman & Renshaw: Raghuram Selvaraju, Aktienanalyst vom Investmenthaus Rodman & Renshaw, spricht im Rahmen einer ...

Rodman starts BioSpecifics at buy

Rodman & Renshaw has started coverage of BioSpecifics Technologies (NASDAQ:BSTC) with a “buy” rating and 12-month price target of $60. The stock closed at $35.97 on Monday. The company’s sol...

Rodman starts Nanosphere at buy

Rodman & Renshaw has launched coverage of Nanosphere (NASDAQ:NSPH) with a “buy” rating and price target of $2. The stock closed at 87 cents on Monday. “In our view, the company’s Verigene ...

Rodman starts EyeGate Pharma at buy

Rodman & Renshaw has launched coverage of EyeGate Pharmaceuticals (NASDAQ:EYEG) with a “buy’ rating and a 12-month price target of $10. The stock closed at $1.70 on Friday. “In our view, the...

Rodman starts Bio-Path at buy

Rodman & Renshaw has launched coverage of Bio-Path Holdings (NASDAQ:BPTH) with a “buy” rating and a 12-month price target of $5. The stock closed at $2.76 on Monday. “In our view, Bio-Path...

Rodman starts InspireMD at buy

Rodman & Renshaw has initiated coverage of InspireMD (NYSE MKT:NSPR) with a “buy” rating and 12-month price target of $4. The stock closed at 71 cents on Thursday. InspireMD is a commercial-st...

Rodman starts VolitionRx at buy

Rodman & Renshaw has initiated coverage of VolitionRx (NASDAQ:VNRX) with a “buy” rating and a 12-month price target of $12. The stock closed at $3.77 on Friday. “In our view, the company’s...

Drugs and Medications [5 Associated Drugs and Medications listed on BioPortfolio]

Creon [Abbott Products, Inc.]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON.CREON (pancrelipase) delayed-release capsules for oral useIni...

Pancreaze [Ortho-McNeil-Janssen Pharmaceutical, Inc.]

These highlights do not include all the information needed to use PANCREAZE™ safely and effectively. See full prescribing information for PANCREAZE™.  PANCREAZE™ (pancrelipase) delayed-release ...

Creon [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) capsule, delayed release for oral use I...

Pancrelipase [X-GEN Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use pancrelipase safely and effectively. See full prescribing information for pancrelipase. pancrelipase (pancrelipase) CAPSULE, DELAYED R...

Zenpep [Eurand Pharmaceuticals Inc.]

These highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP. ZENPEP (pancrelipase) delayed release capsules Initial U.S...

PubMed Articles [53 Associated PubMed Articles listed on BioPortfolio]

Family Conferences in the Neonatal ICU: Observation of Communication Dynamics and Contributions.

Clinicians in the neonatal ICU must engage in clear and compassionate communication with families. Empirical, observational studies of neonatal ICU family conferences are needed to develop counseling ...

A Theoretical Model for the Associative Nature of Conference Participation.

Participation in conferences is an important part of every scientific career. Conferences provide an opportunity for a fast dissemination of latest results, discussion and exchange of ideas, and broad...

Understanding the challenges to facilitating active learning in the resident conferences: a qualitative study of internal medicine faculty and resident perspectives.

In the Next Accreditation System, the Accreditation Council for Graduate Medical Education outlines milestones for medical knowledge and requires regular didactic sessions in residency training. There...

Upcoming Conferences.

Upcoming Conferences.

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

Intervention of Psychological and Ethical Professionals of Human Science in Obstetrical Morbidity and Mortality Conferences (OPEN : Organization, Practices Evaluation in Perinatal Network)

This cluster-randomised controlled trial will test the hypothesis that a multifaceted program with psychological intervention in morbidity mortality conferences (MMC) improve care quality ...

How Does the Spirituality of Patients With Type 2 Diabetes Influence Their Self-management?

This exploratory study is researching how the spirituality of a group of British patients with type 2 diabetes (T2D), impacts their approach to the self-management of their condition. ...

Distant Delivery of a Mindfulness-based Intervention for People Affected by Parkinson's Disease

Psychological difficulties, especially depression and anxiety are the most prevalent non-motor symptoms in Parkinson's Disease (PD). Pharmacological treatments are not as effective in PD. ...

Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk

Young female counselees (18-30 years) belonging to HBOC families with a known mutation on BRCA-genes or not, receive a lot of information regarding their cancer risk. Information sources a...

Healthy Lifestyles for People With Intellectual Disabilities

Relatively few health promotion and disease prevention programs have included or targeted people with disabilities, and even fewer have focused on individuals with intellectual disabilitie...

Companies [180 Associated Companies listed on BioPortfolio]

Rodman & Renshaw, LLC

Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM) is a holding company with a number of direct and indirect subsidiaries, including Rodman & Renshaw, LLC.

Rodman & Renshaw Conferences, LLC

Rodman & Renshaw, LLC Rodman & Renshaw, LLC and Cowen and Company acts as Exclusive Co-Placement Agents to Access Pharmaceuticals, Inc. in the Private Placement of $5.2 Million

Advaxis, Inc. and Rodman & Renshaw, LLC

Advaxis is a biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based on a novel platform tech...

Rodman Publishing

Rodman Publishing, based in Ramsey, New Jersey, has been a leading publisher of trade publications for more than four decades. Established in 1964, Rodman Publishing has been the leading source of inf...

More Information about "Rodman & Renshaw Conferences, LLC" on BioPortfolio

We have published hundreds of Rodman & Renshaw Conferences, LLC news stories on BioPortfolio along with dozens of Rodman & Renshaw Conferences, LLC Clinical Trials and PubMed Articles about Rodman & Renshaw Conferences, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rodman & Renshaw Conferences, LLC Companies in our database. You can also find out about relevant Rodman & Renshaw Conferences, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record